Abstract:The aims of tuberculosis therapy are to cure the patient and to reduce the transmission of its etiologic agent, Mycobacterium tuberculosis , to both immunosuppressed and immunocompetent people. Although the expected rate of cure of antituberculosis treatment based on laboratory results is remarkably high, this efficacy does not always translate to effectiveness. The effectiveness of tuberculosis treatment corresponds to the successful outcome (cure) under operational conditions. Unsuccessful tuberculosis outcomes (death, loss to follow-up, or treatment failure) are associated with different variables, such as patient-related factors (age, comorbidities, individual vulnerability to toxicities, immune status, nutritional status, alcohol intake, adherence to treatment, drug tolerance, and genetic characteristics), organism/disease presentation-related factors (virulence of the organism, radiological extent of the disease, and susceptibility of the strain), care-related factors (motivational capacity of the staff, access of patients to the health care system, and monitoring and supervision of patients regarding treatment), and treatment-related factors (amount of each drug administered, plasma concentrations of administered drugs, relationship between administered drugs and proteins, clearance, metabolism, and absorption; drug bioavailability of the presentations, drug interactions with other drugs, treatment regimen, bactericidal and sterilizing potency, and drug synergy or antagonism). 1 1 Rabahi MF, Silva Júnior JLRD, Ferreira ACG, Tannus-Silva DGS, Conde MB. Tuberculosis treatment [published correction appears in J Bras Pneumol. 2018 Jul-Sep;44(4):340]. J Bras Pneumol. 2017;43(6):472-486. https://doi.org/10.1590/S1806-37562016000000388 https://doi.org/10.1590/S1806-3756201600... A study analyzing the temporal trend of tuberculosis cure indicators in Brazil is presented in this issue of the Jornal Brasileiro de Pneumologia . 2 2 Pavinati G, Lima LV, Bernardo PHP, Dias JR, Reis-Santos B, Magnabosco GT. A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022. J Bras Pneumol. 2024;50(2):e20240018. Pavinati et al. 2 2 Pavinati G, Lima LV, Bernardo PHP, Dias JR, Reis-Santos B, Magnabosco GT. A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022. J Bras Pneumol. 2024;50(2):e20240018. conducted an ecological time-series study using administrative data of reported cases of tuberculosis nationwide from 2001 to 2022. The authors of the study showed a decreasing trend toward cure indicators for new cases of pulmonary tuberculosis, cases of tuberculosis-HIV coinfection, and cases of retreatment, although results were heterogenous among the Brazilian Federative Units. The influence of the COVID-19 pandemic on the outcomes of this analysis is unmistakable. Nevertheless, a discernible trend was noticed across the three groups studied. Although a first increase in the percentages of cure was noted during the first temporal segment of the investigation, this was followed by a reversal of that trend in the later intervals, characterized by a decrease in cure rates. This observation became more marked in the final segment. These findings suggest that independent of the COVID-19 pandemic, other factors were already at play, contributing to the diminishing rates of tuberculosis cure in Brazil. These findings go in the opposite direction to the global average data. 3 3 World Health Organization (WHO). Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. According to the WHO report 2023, there is an increasing trend toward the cure indicator worldwide among people newly diagnosed with tuberculosis and enrolled on first-line treatment, with a success rate of 88% for those enrolled in 2021. 3 3 World Health Organization (WHO). Global Tuberculosis Report 2023. Geneva: World Health Organization; 2023. Licence: CC BY-NC-SA 3.0 IGO. Data from a very recent epidemiological report of the Ministry of Health of Brazil showed a decrease in the cure rate of sensitive cases of tuberculosis (from 76.5% in 2013 to 73.8% in 2019). 4 4 Brasil. Ministério da Saúde. Secretaria de Vigilância em Saúde e Ambiente. Boletim Epidemiológico. Tubercul -Abstract Truncated-

Unsuccessful tuberculosis treatment outcomes across Brazil's geographical landscape before and during the COVID-19 pandemic: are we truly advancing toward the sustainable development/end TB goal?

IMPACT OF THE COVID-19 PANDEMIC ON TUBERCULOSIS CONTROL IN BAHIA

Crucial Actions for Intensifying Efforts

Tuberculosis healthcare service disruptions during the COVID-19 pandemic in Brazil, India and South Africa: A model-based analysis of country-level data

Advances in the development of new vaccines for tuberculosis and Brazil's role in the effort forward the end TB strategy

Prevalence and Spatial Autocorrelation of Tuberculosis in Indigenous People in Brazil, 2002-2022

A critical analysis of the decreasing trends in tuberculosis cure indicators in Brazil, 2001-2022

Retreatment and Antituberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study

Predictors of unsuccessful tuberculosis treatment outcomes in Brazil: an analysis of 259,484 patient records

A decline in tuberculosis diagnosis, treatment initiation and success during the COVID-19 pandemic, using routine health data in Cape Town, South Africa

Mitigating adverse outcomes in tuberculosis treatment: analyzing a non-compliance risk assessment strategy in a case report

Factors associated with unsuccessful tuberculosis treatment in Manaus, Amazonas, from 2011 to 2021

Temporal Pattern and Spatial Distribution of Tuberculosis Prevalence Associated with Multimorbidity in Brazil

Decreasing trends in tuberculosis cure indicators in Brazil

Impact of the improvement of living conditions on tuberculosis mortality in Brazil: an ecological study

Global Tuberculosis Report 2020 – Reflections on the Global TB burden, treatment and prevention efforts

Impact of the COVID-19 Pandemic on Tuberculosis Testing and Treatment at a Tertiary Hospital in Zambia

Long-term survival and cause-specific mortality of patients newly diagnosed with tuberculosis in São Paulo state, Brazil, 2010-15: a population-based, longitudinal study

The geographical distribution and socioeconomic risk factors of COVID-19, tuberculosis and leprosy in Fortaleza, Brazil

Regional disparities in BCG vaccination coverage and tuberculosis incidence in infants among Brazilian states

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020